Venture capitalists across the U.S. pumped more money into promising companies in the second quarter of 2011 than they have in three years. Investments totaled $7.5 billion, more than in any three-month period since the second quarter of 2008, with software, biotech and industrial/energy companies attracting more than 85 percent of the funds, according to a PricewaterhouseCoopers/National Venture Capital Association MoneyTree report.
In Wisconsin, investors reported $39.3 million of venture capital allocations and five of the six deals went to Madison companies. But most of the money went to one place: stem cell company Cellular Dynamics International, which raised $30 million.